Taken together, treatment with MDCO-216 partially reverses cardiac hypertrophy under conditions of continued subcutaneous infusion of angiotensin II (600 ng/kg/min) in combination with 1% NaCl in the drinking water. The gene discussed is AGT; the disease is cardiac hypertrophy.